Evidence map›Paper›PMID 9116754›Full record

ReviewWorld journal of urology1995

Growth factors in bladder cancer.

M Liebert

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 14 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

M LiebertDepartment of Urology and Cell Biology, The University of Texas, Houston 77030, USA.
University of Houston · US

Funding

PROGNOSTIC MARKERS OF URINARY BLADDER CANCERU01CA056973 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI GROSSMAN, H. BARTON · 1992 to 1999
–
NCI NIH HHS U01-CA56973
6 · The paper itself

Abstract

This article is an overview of peptide growth factors, their receptors, and signal-transduction pathways that play a role in bladder cancer. Included in this overview are epidermal growth factor receptor and its ligands, erbB2, fibroblast growth factors, insulin-like growth factor, the transferrin receptor, and transforming growth factor-beta. The use of growth factors or growth factor receptors for diagnostic and therapeutic interventions is also discussed.

Indexed as

AnimalsErbB ReceptorsFibroblast Growth FactorsGenes, erbB-2Growth SubstancesHumansReceptors, TransferrinSomatomedinsTransforming Growth Factor betaUrinary Bladder NeoplasmsErbB ReceptorsFibroblast Growth FactorsGrowth SubstancesReceptors, TransferrinSomatomedinsTransforming Growth Factor beta

Identifiers

PMID9116754
OpenAlexW1991504833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.